Home/Synerkine Pharma/Theo Dinklo

TD

Theo Dinklo

VP, R&D

Synerkine Pharma

Therapeutic Areas

Chronic Pain Neuropathic Pain

Synerkine Pharma Pipeline

Drug	Indication	Phase
SK-01	Complex Regional Pain Syndrome (CRPS) / Chronic Pain	Pre-clinical
SK-02	Chemotherapy-Induced Peripheral Neuropathy (CIPN)	Pre-clinical

Leadership Team at Synerkine Pharma

Emilie Rodrigues

Director CMC Development

View full Synerkine Pharma profile